Latest filingSep 09, 2026Most recent Form 4
SRPT
Sarepta Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/09 to 09/09. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$04 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period4transactions
- F · Tax withholding · dominant4 · 100%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Chief financial officer · dominant1 · 14%
- COO1 · 14%
- DTO1 · 14%
- EVP1 · 14%
- GC1 · 14%
- PRES1 · 14%
- R1 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeRodino-Klapac LouiseCommon Stock · Direct
203,900Sep 04, 2026
Rothfuss CristinCommon Stock · Direct
115,519Sep 04, 2026
Estepan Ian MichaelCommon Stock · Direct
177,184Sep 04, 2026
Wong Ryan Ho-YanCommon Stock · Direct
121,792Sep 04, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 09 → Sep 09
LessMore
Top insiders
By absolute net value across the selected period- EM-$551.0k
- RC-$489.4k
- RL-$476.0k
- WH-$294.9k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
SRPT transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Wong Ryan Ho-Yan | CFO | withholding | 13.2k | -$29.4M | F | — | 0.0% | 09/09 | 09/04 |
| SRPT | Estepan Ian Michael | COO | withholding | 24.7k | -$55.1M | F | — | 0.0% | 09/09 | 09/04 |
| SRPT | Rothfuss Cristin | EVPGC | withholding | 22.0k | -$48.9M | F | — | 0.0% | 09/09 | 09/04 |
| SRPT | Rodino-Klapac Louise | PRESRDTO | withholding | 21.4k | -$47.6M | F | — | 0.0% | 09/09 | 09/04 |
Sarepta Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Sarepta Therapeutics, Inc.?
Wong Ryan Ho-Yan, Estepan Ian Michael, Rothfuss Cristin, Rodino-Klapac Louise.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.